Literature DB >> 23818105

Diagnostic criteria for sarcopenia and physical performance.

A Y Bijlsma1, C G M Meskers, N van den Eshof, R G Westendorp, S Sipilä, L Stenroth, E Sillanpää, J S McPhee, D A Jones, M V Narici, H Gapeyeva, M Pääsuke, T Voit, Y Barnouin, J Y Hogrel, G Butler-Browne, A B Maier.   

Abstract

Relative and absolute muscle mass and muscle strength are used as diagnostic criteria for sarcopenia. We aimed to assess which diagnostic criteria are most associated with physical performance in 180 young (18-30 years) and 281 healthy old participants (69-81 years) of the European study MYOAGE. Diagnostic criteria included relative muscle mass (total or appendicular lean mass (ALM) as percentage of body mass), absolute muscle mass (ALM/height squared and total lean mass), knee extension torque, and handgrip strength. Physical performance comprised walking speed, Timed Up and Go test (TUG), and in a subgroup physical fitness. Diagnostic criteria for sarcopenia and physical performance were standardized, and the associations were analyzed using linear regression models stratified by age category, with adjustments for age, gender, and country. In old participants, relative muscle mass was associated with faster walking speed, faster TUG, and higher physical fitness (all p < 0.001). Absolute muscle mass was not associated with physical performance. Knee extension torque and handgrip strength were associated with faster walking speed (both p ≤ 0.003). Knee extension torque was associated with TUG (p = 0.001). Knee extension torque and handgrip strength were not associated with physical fitness. In young participants, there were no significant associations between diagnostic criteria for sarcopenia and physical performance, except for a positive association between relative muscle mass and physical fitness (p < 0.001). Relative muscle mass, defined as lean mass or ALM percentage, was most associated with physical performance. Absolute muscle mass including ALM/height squared was not associated with physical performance. This should be accounted for when defining sarcopenia.

Entities:  

Mesh:

Year:  2013        PMID: 23818105      PMCID: PMC3889901          DOI: 10.1007/s11357-013-9556-5

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  29 in total

1.  Association between sarcopenia and mortality in healthy older people.

Authors:  Daniel Bunout; María P de la Maza; Gladys Barrera; Laura Leiva; Sandra Hirsch
Journal:  Australas J Ageing       Date:  2011-04-13       Impact factor: 2.111

2.  Loss of muscle strength, mass (sarcopenia), and quality (specific force) and its relationship with functional limitation and physical disability: the Concord Health and Ageing in Men Project.

Authors:  Noran N Hairi; Robert G Cumming; Vasi Naganathan; David J Handelsman; David G Le Couteur; Helen Creasey; Louise M Waite; Markus J Seibel; Philip N Sambrook
Journal:  J Am Geriatr Soc       Date:  2010-11       Impact factor: 5.562

3.  Reduced lean mass in early Alzheimer disease and its association with brain atrophy.

Authors:  Jeffrey M Burns; David K Johnson; Amber Watts; Russell H Swerdlow; William M Brooks
Journal:  Arch Neurol       Date:  2010-04

4.  Adiposity to muscle ratio predicts incident physical limitation in a cohort of 3,153 older adults--an alternative measurement of sarcopenia and sarcopenic obesity.

Authors:  Tung Wai Auyeung; Jenny Shun Wah Lee; Jason Leung; Timothy Kwok; Jean Woo
Journal:  Age (Dordr)       Date:  2012-05-22

5.  Musculoskeletal pain and use of analgesics in relation to mobility limitation among community-dwelling persons aged 75 years and older.

Authors:  N Karttunen; K Lihavainen; S Sipilä; T Rantanen; R Sulkava; S Hartikainen
Journal:  Eur J Pain       Date:  2012-01       Impact factor: 3.931

6.  Sarcopenia and osteopenia among 70-80-year-old home-dwelling Finnish women: prevalence and association with functional performance.

Authors:  R Patil; K Uusi-Rasi; M Pasanen; P Kannus; S Karinkanta; H Sievänen
Journal:  Osteoporos Int       Date:  2012-06-12       Impact factor: 4.507

7.  Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia.

Authors:  Roger A Fielding; Bruno Vellas; William J Evans; Shalender Bhasin; John E Morley; Anne B Newman; Gabor Abellan van Kan; Sandrine Andrieu; Juergen Bauer; Denis Breuille; Tommy Cederholm; Julie Chandler; Capucine De Meynard; Lorenzo Donini; Tamara Harris; Aimo Kannt; Florence Keime Guibert; Graziano Onder; Dimitris Papanicolaou; Yves Rolland; Daniel Rooks; Cornel Sieber; Elisabeth Souhami; Sjors Verlaan; Mauro Zamboni
Journal:  J Am Med Dir Assoc       Date:  2011-03-04       Impact factor: 4.669

Review 8.  Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives.

Authors:  Y Rolland; S Czerwinski; G Abellan Van Kan; J E Morley; M Cesari; G Onder; J Woo; R Baumgartner; F Pillard; Y Boirie; W M C Chumlea; B Vellas
Journal:  J Nutr Health Aging       Date:  2008 Aug-Sep       Impact factor: 4.075

9.  Clinical relevance of different muscle strength indexes and functional impairment in women aged 75 years and older.

Authors:  Sébastien Barbat-Artigas; Yves Rolland; Matteo Cesari; Gabor Abellan van Kan; Bruno Vellas; Mylène Aubertin-Leheudre
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-12-21       Impact factor: 6.053

10.  Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort.

Authors:  A Y Bijlsma; C G M Meskers; C H Y Ling; M Narici; S E Kurrle; I D Cameron; R G J Westendorp; A B Maier
Journal:  Age (Dordr)       Date:  2013-06
View more
  23 in total

1.  Complexity of knee extensor torque in patients with frailty syndrome: a cross-sectional study.

Authors:  Bianca Ferdin Carnavale; Elie Fiogbé; Ana Claudia Silva Farche; Aparecida Maria Catai; Alberto Porta; Anielle Cristhine de Medeiros Takahashi
Journal:  Braz J Phys Ther       Date:  2018-12-20       Impact factor: 3.377

2.  International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management.

Authors:  E Dent; J E Morley; A J Cruz-Jentoft; H Arai; S B Kritchevsky; J Guralnik; J M Bauer; M Pahor; B C Clark; M Cesari; J Ruiz; C C Sieber; M Aubertin-Leheudre; D L Waters; R Visvanathan; F Landi; D T Villareal; R Fielding; C W Won; O Theou; F C Martin; B Dong; J Woo; L Flicker; L Ferrucci; R A Merchant; L Cao; T Cederholm; S M L Ribeiro; L Rodríguez-Mañas; S D Anker; J Lundy; L M Gutiérrez Robledo; I Bautmans; I Aprahamian; J M G A Schols; M Izquierdo; B Vellas
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

3.  Skeletal muscle mass and quality as risk factors for postoperative outcome after open colon resection for cancer.

Authors:  B C Boer; F de Graaff; M Brusse-Keizer; D E Bouman; C H Slump; M Slee-Valentijn; J M Klaase
Journal:  Int J Colorectal Dis       Date:  2016-02-15       Impact factor: 2.571

Review 4.  Sarcopenia and its relationship with osteoarthritis: risk factor or direct consequence?

Authors:  R Papalia; B Zampogna; G Torre; A Lanotte; S Vasta; E Albo; A Tecame; V Denaro
Journal:  Musculoskelet Surg       Date:  2014-01-31

5.  Body composition as a predictor of physical performance in older age: A ten-year follow-up of the Helsinki Birth Cohort Study.

Authors:  Tuija M Mikkola; Mikaela B von Bonsdorff; Minna K Salonen; Mika Simonen; Pertti Pohjolainen; Clive Osmond; Mia-Maria Perälä; Taina Rantanen; Eero Kajantie; Johan G Eriksson
Journal:  Arch Gerontol Geriatr       Date:  2018-05-14       Impact factor: 3.250

6.  Prevalence of sarcopenia and sarcopenic obesity in older German men using recognized definitions: high accordance but low overlap!

Authors:  W Kemmler; M Teschler; A Weißenfels; C Sieber; E Freiberger; S von Stengel
Journal:  Osteoporos Int       Date:  2017-02-20       Impact factor: 4.507

7.  Peak muscle mass in young men and sarcopenia in the ageing male.

Authors:  M Frost; T L Nielsen; K Brixen; M Andersen
Journal:  Osteoporos Int       Date:  2014-11-22       Impact factor: 4.507

8.  Angiotensin-Converting Enzyme Inhibitors and Parameters of Sarcopenia: Relation to Muscle Mass, Strength and Function: Data from the Berlin Aging Study-II (BASE-II).

Authors:  Dominik Spira; Jeremy Walston; Nikolaus Buchmann; Jivko Nikolov; Ilja Demuth; Elisabeth Steinhagen-Thiessen; Rahel Eckardt; Kristina Norman
Journal:  Drugs Aging       Date:  2016-11       Impact factor: 3.923

9.  The Association between Parameters of Malnutrition and Diagnostic Measures of Sarcopenia in Geriatric Outpatients.

Authors:  Esmee M Reijnierse; Marijke C Trappenburg; Morena J Leter; Gerard Jan Blauw; Marian A E de van der Schueren; Carel G M Meskers; Andrea B Maier
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

Review 10.  Physical activity in older age: perspectives for healthy ageing and frailty.

Authors:  Jamie S McPhee; David P French; Dean Jackson; James Nazroo; Neil Pendleton; Hans Degens
Journal:  Biogerontology       Date:  2016-03-02       Impact factor: 4.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.